Page last updated: 2024-08-23

idarubicin and Cancer of Head

idarubicin has been researched along with Cancer of Head in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Amin, M; Ghaffari, MA; Ghanemi, M; Jamalan, M; Kheirollah, A; Pourshohod, A; Zeinali, M	1

Other Studies

1 other study(ies) available for idarubicin and Cancer of Head

Article	Year
Specific Targeting of HER2-Positive Head and Neck Squamous Cell Carcinoma Line HN5 by Idarubicin-ZHER2 Affibody Conjugate. Current cancer drug targets, 2019, Volume: 19, Issue:1 Topics: Antibodies, Monoclonal; Cell Proliferation; Cell Survival; Drug Delivery Systems; Escherichia coli; Head and Neck Neoplasms; Humans; Idarubicin; Immunoconjugates; MCF-7 Cells; Molecular Targeted Therapy; Plasmids; Receptor, ErbB-2; Recombinant Fusion Proteins; Squamous Cell Carcinoma of Head and Neck	2019

Article

Year

Specific Targeting of HER2-Positive Head and Neck Squamous Cell Carcinoma Line HN5 by Idarubicin-ZHER2 Affibody Conjugate.

Current cancer drug targets, 2019, Volume: 19, Issue:1

Topics: Antibodies, Monoclonal; Cell Proliferation; Cell Survival; Drug Delivery Systems; Escherichia coli; Head and Neck Neoplasms; Humans; Idarubicin; Immunoconjugates; MCF-7 Cells; Molecular Targeted Therapy; Plasmids; Receptor, ErbB-2; Recombinant Fusion Proteins; Squamous Cell Carcinoma of Head and Neck

2019